ARCC-4
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-130492-5 mg |
| CAS # | 1973403-00-7 |
| Pricing | 5 mg, USD $1250.0 |
| Biological Activity | ARCC-4 is a low-nanomolar androgen receptor (AR) degrader based on PROTAC, with a DC50 of 5 nM. ARCC-4 is an enzalutamide-based von Hippel-Lindau (VHL)-recruiting AR PROTAC and outperforms enzalutamide. ARCC-4 effectively degrades clinically relevant AR mutants associated with antiandrogen therapy[1]. |
| Purity | 99.54% |
| MWt | 1024.18 |
| Formula | C₅₃H₅₆F₃N₇O₇S₂ |